{
    "moduleId": "module_03",
    "moduleTitle": "O: Options Explored",
    "passingScore": 80,
    "questions": [
        {
            "id": "q3_1",
            "question": "Which dietary modification has been shown to significantly reduce the frequency and severity of hot flashes in perimenopausal women, according to a 2021 meta-analysis?",
            "options": ["Increasing simple carbohydrate intake", "Following a Mediterranean diet rich in fruits, vegetables, and whole grains", "Eliminating all dairy products", "Consuming a high-protein, low-carbohydrate diet"],
            "correctAnswer": 1,
            "explanation": "A Mediterranean diet, rich in fruits, vegetables, and whole grains, has been associated with reduced hot flashes. The 2021 meta-analysis supported this finding."
        },
        {
            "id": "q3_2",
            "question": "A 52-year-old woman, Sarah, reports difficulty sleeping and increased stress levels during perimenopause. Which exercise modality is MOST likely to improve her sleep quality and reduce stress, based on evidence-based recommendations?",
            "options": ["High-intensity interval training (HIIT) performed in the evening", "Vigorous weightlifting sessions four times per week", "Yoga and mindfulness-based movement practices", "Long-distance running exceeding 5 miles daily"],
            "correctAnswer": 2,
            "explanation": "Yoga and mindfulness-based movement practices are effective for improving sleep quality and reducing stress due to their emphasis on relaxation and stress reduction. HIIT and intense weightlifting might be too stimulating before bed."
        },
        {
            "id": "q3_3",
            "question": "According to the North American Menopause Society (NAMS), what is the most effective treatment for vasomotor symptoms (VMS) in perimenopausal and menopausal women?",
            "options": ["Black cohosh supplements", "Low-dose hormone therapy (HT)", "Acupuncture", "Soy isoflavones"],
            "correctAnswer": 1,
            "explanation": "NAMS guidelines consistently recommend low-dose hormone therapy as the most effective treatment for vasomotor symptoms, provided it is appropriate for the individual's health profile."
        },
        {
            "id": "q3_4",
            "question": "What is a potential risk associated with systemic hormone therapy (HT) that should be discussed with patients, especially those with a family history of breast cancer?",
            "options": ["Increased risk of osteoporosis", "Decreased risk of cardiovascular disease", "Increased risk of endometrial cancer with estrogen-only therapy (in women with a uterus)", "Reduced risk of blood clots"],
            "correctAnswer": 2,
            "explanation": "Estrogen-only therapy (in women with a uterus) increases the risk of endometrial cancer if not balanced with progestogen. Systemic HT also carries a slightly increased risk of blood clots and stroke."
        },
        {
            "id": "q3_5",
            "question": "Which non-hormonal medication is an SSRI approved by the FDA to treat moderate to severe vasomotor symptoms (VMS) associated with menopause?",
            "options": ["Gabapentin", "Clonidine", "Paroxetine (Brisdelle)", "Oxybutynin"],
            "correctAnswer": 2,
            "explanation": "Paroxetine (Brisdelle) is a selective serotonin reuptake inhibitor (SSRI) specifically approved by the FDA for the treatment of moderate to severe vasomotor symptoms associated with menopause."
        },
        {
            "id": "q3_6",
            "question": "A 55-year-old woman, Maria, is experiencing vaginal dryness and dyspareunia (painful intercourse) after menopause. Which non-hormonal treatment is MOST likely to provide localized relief with minimal systemic absorption?",
            "options": ["Oral estrogen therapy", "Systemic hormone therapy", "Vaginal moisturizers and lubricants", "Oral selective estrogen receptor modulators (SERMs)"],
            "correctAnswer": 2,
            "explanation": "Vaginal moisturizers and lubricants provide localized relief for vaginal dryness and dyspareunia with minimal systemic absorption, making them a first-line treatment option."
        },
        {
            "id": "q3_7",
            "question": "What is the primary concern when considering the use of compounded bioidentical hormone therapy (cBHT) compared to FDA-approved hormone therapy?",
            "options": ["cBHT is more effective for treating vasomotor symptoms.", "cBHT is rigorously tested and regulated by the FDA.", "The doses and purity of cBHT are not standardized, leading to potential inconsistencies and safety concerns.", "cBHT is significantly less expensive than FDA-approved HT."],
            "correctAnswer": 2,
            "explanation": "The primary concern with cBHT is the lack of standardization in doses and purity, which can lead to inconsistencies and potential safety risks, as it is not subject to the same rigorous testing and regulation as FDA-approved HT."
        },
        {
            "id": "q3_8",
            "question": "Which of the following alternative therapies has shown some evidence for improving sleep quality in menopausal women, although the evidence is not conclusive and requires further research?",
            "options": ["Magnet therapy", "Aromatherapy with lavender essential oil", "Crystal healing", "Cupping therapy"],
            "correctAnswer": 1,
            "explanation": "Aromatherapy with lavender essential oil has shown some promise in improving sleep quality in menopausal women, although more rigorous research is needed to confirm these findings. A 2015 systematic review noted potential benefits."
        },
        {
            "id": "q3_9",
            "question": "A 48-year-old woman, Lisa, is hesitant about hormone therapy due to concerns about breast cancer. She experiences mild hot flashes and night sweats that interfere with her sleep. Which of the following would be the MOST appropriate initial step in developing a personalized treatment plan?",
            "options": ["Immediately prescribing high-dose estrogen therapy", "Recommending black cohosh and St. John's Wort", "Implementing lifestyle modifications such as exercise, stress management, and dietary changes", "Referring her directly for a bilateral oophorectomy"],
            "correctAnswer": 2,
            "explanation": "Implementing lifestyle modifications is the most appropriate initial step for women with mild symptoms and concerns about hormone therapy. This approach is low-risk and can often effectively manage symptoms."
        },
        {
            "id": "q3_10",
            "question": "When communicating with a patient about the risks and benefits of hormone therapy, which approach is MOST effective in addressing misinformation and promoting informed decision-making?",
            "options": ["Dismissing their concerns as unfounded and relying solely on statistical data.", "Presenting only the benefits of hormone therapy to alleviate their fears.", "Acknowledging their concerns, providing evidence-based information from reputable sources like NAMS, and engaging in shared decision-making.", "Avoiding the topic of hormone therapy altogether to prevent anxiety."],
            "correctAnswer": 2,
            "explanation": "Acknowledging patient concerns, providing evidence-based information, and engaging in shared decision-making is the most effective approach for addressing misinformation and promoting informed choices. This builds trust and empowers patients to make decisions aligned with their values and preferences."
        }
    ]
}